Relief of Two Built-In Autoinhibitory Mechanisms in P-TEFb Is Required for Assembly of a Multicomponent Transcription Elongation Complex at the Human Immunodeficiency Virus Type 1 Promoter

ABSTRACT Tat stimulation of human immunodeficiency virus type 1 (HIV-1) transcription requires Tat-dependent recruitment of human positive transcription elongation factor b (P-TEFb) to the HIV-1 promoter and the formation on the trans-acting response element (TAR) RNA of a P-TEFb–Tat–TAR ternary complex. We show here that the P-TEFb heterodimer of Cdk9-cyclin T1 is intrinsically incapable of forming a stable complex with Tat and TAR due to two built-in autoinhibitory mechanisms in P-TEFb. Both mechanisms exert little effect on the P-TEFb–Tat interaction but prevent the P-TEFb–Tat complex from binding to TAR RNA. The first autoinhibition arises from the unphosphorylated state of Cdk9, which establishes a P-TEFb conformation unfavorable for TAR recognition. Autophosphorylation of Cdk9 overcomes this inhibition by inducing conformational changes in P-TEFb, thereby exposing a region in cyclin T1 for possible TAR binding. An intramolecular interaction between the N- and C-terminal regions of cyclin T1 sterically blocks the P-TEFb–TAR interaction and constitutes the second autoinhibitory mechanism. This inhibition is relieved by the binding of the C-terminal region of cyclin T1 to the transcription elongation factor Tat-SF1 and perhaps other cellular factors. Upon release from the intramolecular interaction, the C-terminal region also interacts with RNA polymerase II and is required for HIV-1 transcription, suggesting its role in bridging the P-TEFb–Tat–TAR complex and the basal elongation apparatus. These data reveal novel control mechanisms for the assembly of a multicomponent transcription elongation complex at the HIV-1 promoter.

[1]  D. Chen,et al.  Requirement for a Kinase-specific Chaperone Pathway in the Production of a Cdk9/Cyclin T1 Heterodimer Responsible for P-TEFb-mediated Tat Stimulation of HIV-1 Transcription* , 2000, The Journal of Biological Chemistry.

[2]  K. Jeang,et al.  Multifaceted Activities of the HIV-1 Transactivator of Transcription, Tat* , 1999, The Journal of Biological Chemistry.

[3]  P. Sharp,et al.  Tat-SF1 Protein Associates with RAP30 and Human SPT5 Proteins , 1999, Molecular and Cellular Biology.

[4]  B. Ma,et al.  SNAP(c): a core promoter factor with a built-in DNA-binding damper that is deactivated by the Oct-1 POU domain. , 1999, Genes & development.

[5]  R. Roeder,et al.  A novel RNA polymerase II‐containing complex potentiates Tat‐enhanced HIV‐1 transcription , 1999, The EMBO journal.

[6]  R. Gaynor,et al.  Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation. , 1999, Journal of molecular biology.

[7]  Hiroshi Handa,et al.  NELF, a Multisubunit Complex Containing RD, Cooperates with DSIF to Repress RNA Polymerase II Elongation , 1999, Cell.

[8]  D. Chen,et al.  Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the species-specific Tat activation of HIV-1 transcription. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  B. Peterlin,et al.  Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[10]  X. Graña,et al.  Upregulation of cyclin T1/CDK9 complexes during T cell activation , 1998, Oncogene.

[11]  H. Handa,et al.  Evidence that P‐TEFb alleviates the negative effect of DSIF on RNA polymerase II‐dependent transcription in vitro , 1998, The EMBO journal.

[12]  A. Rice,et al.  Tat-Associated Kinase, TAK, Activity Is Regulated by Distinct Mechanisms in Peripheral Blood Lymphocytes and Promonocytic Cell Lines , 1998, Journal of Virology.

[13]  B. Cullen,et al.  Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV‐1 Tat , 1998, The EMBO journal.

[14]  M. Garber,et al.  The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. , 1998, Genes & development.

[15]  X. Y. Li,et al.  The HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factor. , 1998, Genes & development.

[16]  D. Chen,et al.  Transcription elongation factor P‐TEFb mediates Tat activation of HIV‐1 transcription at multiple stages , 1998, The EMBO journal.

[17]  M. Malim,et al.  HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. , 1998, Science.

[18]  D. Price,et al.  Identification of a Cyclin Subunit Required for the Function ofDrosophila P-TEFb* , 1998, The Journal of Biological Chemistry.

[19]  A. Rice,et al.  PITALRE, the Catalytic Subunit of TAK, Is Required for Human Immunodeficiency Virus Tat Transactivation In Vivo , 1998, Journal of Virology.

[20]  R. Gaynor,et al.  Role of the human homolog of the yeast transcription factor SPT5 in HIV-1 Tat-activation. , 1998, Journal of molecular biology.

[21]  J. Milton,et al.  Identification of multiple cyclin subunits of human P-TEFb. , 1998, Genes & development.

[22]  Ping Wei,et al.  A Novel CDK9-Associated C-Type Cyclin Interacts Directly with HIV-1 Tat and Mediates Its High-Affinity, Loop-Specific Binding to TAR RNA , 1998, Cell.

[23]  A. Hinnebusch,et al.  The Yeast TAF145 Inhibitory Domain and TFIIA Competitively Bind to TATA-Binding Protein , 1998, Molecular and Cellular Biology.

[24]  K. Yano,et al.  DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. , 1998, Genes & development.

[25]  A. Rice,et al.  TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  H. Okamoto,et al.  The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. , 1997, Genes & development.

[27]  D. Hazuda,et al.  P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. , 1997, Genes & development.

[28]  M. Mathews,et al.  Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. , 1997, Genes & development.

[29]  K. Jones,et al.  Taking a new TAK on tat transactivation. , 1997, Genes & development.

[30]  R. Gaynor,et al.  Purification of a Tat‐associated kinase reveals a TFIIH complex that modulates HIV‐1 transcription , 1997, The EMBO journal.

[31]  D. Reinberg,et al.  The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme , 1997, Molecular and cellular biology.

[32]  R. Roeder,et al.  Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain , 1996, Nature.

[33]  K. Jeang,et al.  Requirements for RNA Polymerase II Carboxyl-terminal Domain for Activated Transcription of Human Retroviruses Human T-Cell Lymphotropic Virus I and HIV-1* , 1996, The Journal of Biological Chemistry.

[34]  P. Sharp,et al.  Tat-SF1: Cofactor for Stimulation of Transcriptional Elongation by HIV-1 Tat , 1996, Science.

[35]  D. Price,et al.  Control of RNA Polymerase II Elongation Potential by a Novel Carboxyl-terminal Domain Kinase* , 1996, The Journal of Biological Chemistry.

[36]  H. Okamoto,et al.  Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Dahmus.  Reversible Phosphorylation of the C-terminal Domain of RNA Polymerase II* , 1996, The Journal of Biological Chemistry.

[38]  A. Rice,et al.  The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function , 1996, Journal of virology.

[39]  D. Price,et al.  Purification of P-TEFb, a Transcription Factor Required for the Transition into Productive Elongation (*) , 1995, The Journal of Biological Chemistry.

[40]  P. Sharp,et al.  Novel mechanism and factor for regulation by HIV‐1 Tat. , 1995, The EMBO journal.

[41]  M. Horikoshi,et al.  Interaction between the N-terminal domain of the 230-kDa subunit and the TATA box-binding subunit of TFIID negatively regulates TATA-box binding. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[42]  C. Gross,et al.  Amino-terminal amino acids modulate sigma-factor DNA-binding activity. , 1993, Genes & development.

[43]  R. Roeder,et al.  HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. , 1992, Genes & development.

[44]  P. Sharp,et al.  HIV‐1 Tat protein promotes formation of more‐processive elongation complexes. , 1991, The EMBO journal.

[45]  M. Gillespie,et al.  Autoinhibition as a transcriptional regulatory mechanism. , 1998, Cold Spring Harbor symposia on quantitative biology.